Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound (RADICAL USE)
Primary Purpose
Bradycardia, Brady-tachy Syndrome
Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Ultrasound / Echocardiography
Sponsored by
About this trial
This is an interventional treatment trial for Bradycardia
Eligibility Criteria
Inclusion Criteria:
- Age >18 years old.
- Suitable to have either a single chamber pacemaker or single chamber cardioverter-defibrillator.
Exclusion Criteria:
- BMI >30.
- Pregnancy.
- Implantation of dual-chamber and CRT devices.
- Claustrophobia.
- Tender chest wall or history of trauma to the chest wall.
- Higher signal interference using ultrasound due to the presence of other medical devices or tools used in previous surgical procedures such as sternal wires, mechanical valves, breast implants.
- History of radiation to the chest wall for oncology treatments.
- Active malignancy
Sites / Locations
- London Health Sciences Centre Res. Inc. (Ont.)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Reduced fluoroscopy arm
Conventional arm
Arm Description
Patients exposed to 20 seconds or less of fluoroscopy to implant a single chamber device with aid of ultrasound / echocardiography.
Patients exposed to more than 20 seconds of fluoroscopy to implant a single chamber device with/without the aid of ultrasound / echocardiography.
Outcomes
Primary Outcome Measures
Success of implanting a single chamber lead with use of ultrasound
Binary outcome - successful or not.
Secondary Outcome Measures
Duration of radiation will be measured in seconds
Comparison between the treatment and control group
Total radiation dose will be collected in centiGray and milliGray units.
Comparison between the treatment and control group
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04858698
Brief Title
Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound
Acronym
RADICAL USE
Official Title
Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound (RADICAl USe)
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 30, 2021 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Habib Khan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Specialized equipment is required to put pacemakers in the heart. This requires use of radiation to see the wires or leads being implanted in the heart. Repeated radiation use can result in permanent injury to the patient and to the doctor. The investigators aim to investigate if they can use ultrasound to guide and help in the implantation of leads into the heart. Ultrasound is a safe method and requires only a small handheld probe and a small screen to see different structures in the heart. If ultrasounds proves successful as a tool to reduce radiation then this would be very useful technical breakthrough. It would help develop smaller centres where pacemakers can be implanted without purchasing xray equipment and expensive setups.
Detailed Description
Radiation quantity used in medicine is expanding year on year with increasing clinical uses for medical illnesses and to visualize instruments being used during procedures such as cardiac devices including pacemakers. The effects of radiation are not only on the patients for their procedure but also a cumulative effect of radiation on the operators. The stochastic effects of radiation have been well reported in the literature. Advancing technologies such as 3-dimensional(3D) mapping systems have allowed for leads to be identified using a 3D matrix and safely deployed to the myocardium. However, there are significant costs associated with the use of 3D mapping systems resulting in this approach not being widely adopted. Ultrasound use during implantation of cardiac implantable electronic devices (CIED) has been utilized in the past to gain vascular access via the axillary vein with good safety results. Experimental studies to visualize leads in the heart and venous systems using 3D ultrasound showed optimism but has not translated to clinical use due to lack of technology to improve the spatial and temporal resolution. The technology in imaging resolution has improved over the last 5 years and likely can be used to visualize a pacing lead in the heart. Techniques such as intravascular cardiac ultrasound have been used to assist in implanting lead via coronary sinus in individuals who can have contrast allergies. Therefore, transthoracic echocardiogram and ultrasound should be now of sufficient quality to allow for successful pacemaker insertion.
To date, there has not been a feasibility study to evaluate complete ultrasound and echocardiography-assisted pacemaker insertion.
In this study, the investigators aim to utilize ultrasound and echocardiography to gain vascular access and to direct the pacing lead into the right ventricle to allow for safe pacemaker implantation. If this is successful, then this will allow for a larger study to be conducted for single chamber devices including implantable cardioverter defibrillators. Moreover, the investigators will be able to analyze the cost-effectiveness of this new technique compared to the conventional technique of pacemaker implantation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bradycardia, Brady-tachy Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
66 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Reduced fluoroscopy arm
Arm Type
Experimental
Arm Description
Patients exposed to 20 seconds or less of fluoroscopy to implant a single chamber device with aid of ultrasound / echocardiography.
Arm Title
Conventional arm
Arm Type
Active Comparator
Arm Description
Patients exposed to more than 20 seconds of fluoroscopy to implant a single chamber device with/without the aid of ultrasound / echocardiography.
Intervention Type
Device
Intervention Name(s)
Ultrasound / Echocardiography
Other Intervention Name(s)
Echocardiography by using St Jude - Zonaire ultrasound and P4-1c transducer.
Intervention Description
Ultrasound will be used to guide vascular access and to place a lead into the right ventricle.
Primary Outcome Measure Information:
Title
Success of implanting a single chamber lead with use of ultrasound
Description
Binary outcome - successful or not.
Time Frame
0 day
Secondary Outcome Measure Information:
Title
Duration of radiation will be measured in seconds
Description
Comparison between the treatment and control group
Time Frame
during procedure
Title
Total radiation dose will be collected in centiGray and milliGray units.
Description
Comparison between the treatment and control group
Time Frame
during procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age >18 years old.
Suitable to have either a single chamber pacemaker or single chamber cardioverter-defibrillator.
Exclusion Criteria:
BMI >30.
Pregnancy.
Implantation of dual-chamber and CRT devices.
Claustrophobia.
Tender chest wall or history of trauma to the chest wall.
Higher signal interference using ultrasound due to the presence of other medical devices or tools used in previous surgical procedures such as sternal wires, mechanical valves, breast implants.
History of radiation to the chest wall for oncology treatments.
Active malignancy
Facility Information:
Facility Name
London Health Sciences Centre Res. Inc. (Ont.)
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5A5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Habib I Khan
Phone
5196633135
Email
habib.khan@lhsc.on.ca
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound
We'll reach out to this number within 24 hrs